BioCentury
ARTICLE | Clinical News

DCP-001 regulatory update

February 6, 2012 8:00 AM UTC

EMA's CHMP issued a positive opinion to grant Orphan Drug designation for DCPrime's DCP-001 to treat acute myelogenous leukemia (AML). The off-the-shelf dendritic cell vaccine based on the company's D...